GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Great Basin Scientific Inc (GREY:GBSNQ) » Definitions » ROE %

Great Basin Scientific (Great Basin Scientific) ROE % : Negative Equity% (As of Mar. 2017)


View and export this data going back to 2014. Start your Free Trial

What is Great Basin Scientific ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Great Basin Scientific's annualized net income for the quarter that ended in Mar. 2017 was $86.02 Mil. Great Basin Scientific's average Total Stockholders Equity over the quarter that ended in Mar. 2017 was $-42.92 Mil. Therefore, Great Basin Scientific's annualized ROE % for the quarter that ended in Mar. 2017 was Negative Equity%.

The historical rank and industry rank for Great Basin Scientific's ROE % or its related term are showing as below:

GBSNQ's ROE % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -6.44
* Ranked among companies with meaningful ROE % only.

Great Basin Scientific ROE % Historical Data

The historical data trend for Great Basin Scientific's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Basin Scientific ROE % Chart

Great Basin Scientific Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16
ROE %
- - - - -

Great Basin Scientific Quarterly Data
Dec12 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - Negative Equity

Competitive Comparison of Great Basin Scientific's ROE %

For the Diagnostics & Research subindustry, Great Basin Scientific's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Great Basin Scientific's ROE % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Great Basin Scientific's ROE % distribution charts can be found below:

* The bar in red indicates where Great Basin Scientific's ROE % falls into.



Great Basin Scientific ROE % Calculation

Great Basin Scientific's annualized ROE % for the fiscal year that ended in Dec. 2016 is calculated as

ROE %=Net Income (A: Dec. 2016 )/( (Total Stockholders Equity (A: Dec. 2015 )+Total Stockholders Equity (A: Dec. 2016 ))/ count )
=-89.148/( (-23.195+-55.986)/ 2 )
=-89.148/-39.5905
=N/A %

Great Basin Scientific's annualized ROE % for the quarter that ended in Mar. 2017 is calculated as

ROE %=Net Income (Q: Mar. 2017 )/( (Total Stockholders Equity (Q: Dec. 2016 )+Total Stockholders Equity (Q: Mar. 2017 ))/ count )
=86.016/( (-55.986+-29.861)/ 2 )
=86.016/-42.9235
=Negative Equity %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2017) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


Great Basin Scientific  (GREY:GBSNQ) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2017 )
=Net Income/Total Stockholders Equity
=86.016/-42.9235
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(86.016 / 3.324)*(3.324 / 51.322)*(51.322 / -42.9235)
=Net Margin %*Asset Turnover*Equity Multiplier
=2587.73 %*0.0648*N/A
=ROA %*Equity Multiplier
=167.68 %*N/A
=Negative Equity %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2017 )
=Net Income/Total Stockholders Equity
=86.016/-42.9235
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (86.016 / 86.016) * (86.016 / -25.788) * (-25.788 / 3.324) * (3.324 / 51.322) * (51.322 / -42.9235)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * -3.3355 * -775.81 % * 0.0648 * N/A
=Negative Equity %

Note: The net income data used here is four times the quarterly (Mar. 2017) net income data. The Revenue data used here is four times the quarterly (Mar. 2017) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Great Basin Scientific ROE % Related Terms

Thank you for viewing the detailed overview of Great Basin Scientific's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Great Basin Scientific (Great Basin Scientific) Business Description

Traded in Other Exchanges
N/A
Address
420 East South Temple, Suite 520, Salt Lake City, UT, USA, 84111
Great Basin Scientific Inc is the United States based molecular diagnostic testing company. It is focused on the development and commercialization of molecular diagnostic platform designed to test for the infectious disease, especially hospital-acquired infections. Molecular diagnostic testing reduces test time from days to hours compared to culture methods. The company's system includes an analyzer, which it provides for the customers' use without charge in the United States, and a diagnostic cartridge, which it sells to the customers. The group derives its revenue from the sale of single-use assays sold in the United States, the European Union, and New Zealand, of which majority of the revenue is generated from the United States.

Great Basin Scientific (Great Basin Scientific) Headlines

No Headlines